Simian AIDS induced by SIVmac251/239 is characterized by an accelerated disease progression and by higher set-point plasma viral loads (VLs) compared to HIV-1 infection in humans. The highly pathogenic SIVmac251 originated from serial passages of cross-species transmitted SIVsm from sooty mangabeys SMs) to rhesus macaques (Rh). We propose a new paradigm of AIDS pathogenesis in Rh. Our data strongly indicate that primary SIVsm isolates are less pathogenic in Rh than serially passaged SIVmac251/239. We hypothesize that this low intrinsic pathogenic potential is due to the ability of the host to contain the infection rather than a lower replicative capacity of the virus. A corollary of this hypothesis is that these primary SIVsm isolates may represent an improved model for AIDS, useful for pathogenesis of HIV/SIV infection and vaccine development. To confirm our hypothesis, we propose the following specific aims (SA):
Specific Aim 1 : To assess the in vivo pathogenesis of primary SIVsm strains belonging to selected SIVsm lineages and to compare them to the highly pathogenic prototype SIVmac251. We will extend the preliminary results to acquire statistically significant data and confirm that SIVsm can indeed be controlled by Rh.
This aim consists of 4 parts: SA1 A. To study the in vivo dynamics of primary SIVsm isolates replication in Rh; SA1B. To investigate if the low viral load (VL) set-points in Rh infected with primary SIVsm isolates are due to a more restrictive in vivo tropism; SA1C. To investigate the adaptive immune responses in Rh infected with primary SIVsm isolates; SA1D. To investigate the dynamics of major target cell populations in peripheral blood, lymphoid and intestinal tissues in order to determine if primary SIVsm isolates induce less CD4 destruction.
Specific Aim 2 : To dissect the adaptive immune responses (cellular versus humoral) potentially responsible for increased control of VL in infection with primary SIVsm isolates. The experimental approach includes (a) depletion of CD8+ cells during the acute and chronic phase of infection and (b] depletion of CD20+ cells during the acute phase of infection with a neutralizable SIVsm strain. This new macaque model is highly relevant for public health. Characterizing a group of viruses which are better controlled by the immune system will offer the opportunity to carry out studies to identify the correlates of immune protection in HIV/SIV infections. By providing an array of SIVsm strains showing roughly the same degree of divergence as HIV-1 group M subtypes, our model may be used for the study of heterotypic protection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI065325-01A1
Application #
7062182
Study Section
AIDS Immunology and Pathogenesis Study Section (AIP)
Program Officer
Young, Janet M
Project Start
2006-01-01
Project End
2009-12-31
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
1
Fiscal Year
2006
Total Cost
$614,752
Indirect Cost
Name
Tulane University
Department
Type
Other Domestic Higher Education
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Heusinger, Elena; Deppe, Katja; Sette, Paola et al. (2018) Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2. J Virol 92:
Raehtz, Kevin; Pandrea, Ivona; Apetrei, Cristian (2016) The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression. Infect Genet Evol 46:308-323
Mandell, Daniel T; Kristoff, Jan; Gaufin, Thaidra et al. (2014) Pathogenic features associated with increased virulence upon Simian immunodeficiency virus cross-species transmission from natural hosts. J Virol 88:6778-92
Wijewardana, Viskam; Kristoff, Jan; Xu, Cuiling et al. (2013) Kinetics of myeloid dendritic cell trafficking and activation: impact on progressive, nonprogressive and controlled SIV infections. PLoS Pathog 9:e1003600
Fischer, Will; Apetrei, Cristian; Santiago, Mario L et al. (2012) Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages. J Virol 86:13217-31
Pandrea, Ivona; Parrish, Nicholas F; Raehtz, Kevin et al. (2012) Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites. J Virol 86:4158-68
Pandrea, Ivona; Cornell, Elaine; Wilson, Cara et al. (2012) Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood 120:1357-66
Elliott, Sarah T C; Riddick, Nadeene E; Francella, Nicholas et al. (2012) Cloning and analysis of sooty mangabey alternative coreceptors that support simian immunodeficiency virus SIVsmm entry independently of CCR5. J Virol 86:898-908
Vinton, Carol; Klatt, Nichole R; Harris, Levelle D et al. (2011) CD4-like immunological function by CD4- T cells in multiple natural hosts of simian immunodeficiency virus. J Virol 85:8702-8
Pandrea, Ivona; Gaufin, Thaidra; Gautam, Rajeev et al. (2011) Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion. PLoS Pathog 7:e1002170

Showing the most recent 10 out of 38 publications